Cargando…

Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy

BACKGROUND: Tumor regression grade (TRG) after neoadjuvant therapy is reportedly predictive of prognosis in esophageal cancer patients, as lack of a response to neoadjuvant therapy is associated with a poor prognosis. However, there is little information available on the timing and pattern of recurr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagaki, Yushi, Motoyama, Satoru, Sato, Yusuke, Wakita, Akiyuki, Fujita, Hiromu, Sasaki, Yoshihiro, Imai, Kazuhiro, Minamiya, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576899/ https://www.ncbi.nlm.nih.gov/pubmed/34753448 http://dx.doi.org/10.1186/s12885-021-08918-x

Ejemplares similares

SUV(max) reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
por: Nagaki, Yushi, et al.
Publicado: (2021)

Salvage Robotic-Assisted Thoracoscopic Esophagectomy after Definitive Chemoradiotherapy for Clinical T4b Esophageal Cancer: A Case Report
por: Sasamori, Ryohei, et al.
Publicado: (2021)

Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer
por: Wakita, Akiyuki, et al.
Publicado: (2023)

Salvage esophagectomy under bilateral thoracotomy after definitive chemoradiotherapy for aorta T4 thoracic esophageal squamous cell carcinoma: Report of a case
por: Nagaki, Yushi, et al.
Publicado: (2015)

Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
por: Sato, Yusuke, et al.
Publicado: (2021)

Lower local recurrence rate after robot-assisted thoracoscopic esophagectomy than conventional thoracoscopic surgery for esophageal cancer
por: Motoyama, Satoru, et al.
Publicado: (2021)

Comparison of the incidences of anastomotic leakage when PDSII or LACLON are used in esophago-gastric conduit handsewn anastomosis after esophagectomy
por: Sato, Yusuke, et al.
Publicado: (2020)

Robot-assisted thoracoscopic enucleation for a large esophageal leiomyoma: a case report
por: Kemuriyama, Kohei, et al.
Publicado: (2021)

Evaluation of metastatic lymph nodes in cN0 thoracic esophageal cancer patients with inconsistent pathological lymph node diagnosis
por: Wakita, Akiyuki, et al.
Publicado: (2020)

Differences in treatment and survival between elderly patients with thoracic esophageal cancer in metropolitan areas and other areas
por: Motoyama, Satoru, et al.
Publicado: (2021)

High TLR6 Expression Status Predicts a More Favorable Prognosis after Esophagectomy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
por: Sato, Yusuke, et al.
Publicado: (2023)

Surgical therapy for breast cancer liver metastases
por: Terata, Kaori, et al.
Publicado: (2020)

Two cases of cisplatin-induced permanent renal failure following neoadjuvant chemotherapy for esophageal cancer
por: Sasaki, Tomohiko, et al.
Publicado: (2016)

Ultrasound-guided intranodal lipiodol lymphangiography from the groin is useful for assessment and treatment of post-esophagectomy chylothorax in three cases
por: Liu, Jiajia, et al.
Publicado: (2016)

Loco-regional therapy for isolated locoregional lymph node recurrence of breast cancer: focusing on surgical treatment with combined therapy
por: Terata, Kaori, et al.
Publicado: (2020)

CMV reactivation caused by methylprednisolone therapy for ARDS after esophagectomy
por: Sato, Yusuke, et al.
Publicado: (2012)

A male with primary accessory breast carcinoma in an axilla is strongly suspected of having hereditary breast cancer
por: Takahashi, Eriko, et al.
Publicado: (2021)

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2018)

Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015)

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients
por: FUJIWARA, YOSHINORI, et al.
Publicado: (2012)

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2022)

The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study
por: He, Hongbo, et al.
Publicado: (2022)

Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma
por: FUJIWARA, YOSHINORI, et al.
Publicado: (2013)

The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
por: Park, Seong Yong, et al.
Publicado: (2020)

Inhibition of dendritic cell migration by transforming growth factor-β1 increases tumor-draining lymph node metastasis
por: Imai, Kazuhiro, et al.
Publicado: (2012)

NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY TRANSHITAL ESOPHAGECTOMY IN LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: IMPACT OF PATHOLOGICAL COMPLETE RESPONSE
por: ALVES, Iuri Pedreira Fillardi, et al.
Publicado: (2021)

Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study
por: Takashima, Shinogu, et al.
Publicado: (2020)

Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma
por: Yan, Mao-Hui, et al.
Publicado: (2020)

A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma
por: Koterazawa, Yasufumi, et al.
Publicado: (2018)

The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis
por: Imai, Takeharu, et al.
Publicado: (2021)

Novel method for rapid fluorescence in-situ hybridization of ALK rearrangement using non-contact alternating current electric field mixing
por: Fujishima, Satoshi, et al.
Publicado: (2017)

Esophageal cancer with right vertebral artery variation observed during thoracoscopic esophagectomy: a case report
por: Sato, Yuta, et al.
Publicado: (2021)

Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma
por: Murakami, Yuji, et al.
Publicado: (2018)

Cytomegalovirus-associated ulceration of gastric conduit after chemoradiotherapy following esophagectomy for cancer
por: Matsuda, Yasunori, et al.
Publicado: (2014)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
por: Gao, Hui‐Jiang, et al.
Publicado: (2020)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
por: Zhao, Junfeng, et al.
Publicado: (2023)

Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer: a European multicenter study
por: Schuring, N, et al.
Publicado: (2022)

Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy
por: van der Wilk, Berend J., et al.
Publicado: (2023)

Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Chang, Yi-Lin, et al.
Publicado: (2022)

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer
por: Brinkmann, Sebastian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bnm2oq7dmd48fsail19lmn1b2f